Serge Saxonov, CEO of 10x Genomics ($TXG), sold about $1 million in shares across six open market transactions in the past year, with his latest sale on March 2, 2026. He ranks 4,907th out of 11,678 insiders by total sales value, well below the average of $8.6 million and 6.4 transactions. Saxonov made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 5000 | $19.52 | 1,457,194.0000 | 127,691,329 | 0.34% | 0.00% |
| March 23, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 10000 | $19.13 | 1,462,194.0000 | 127,691,329 | 0.68% | 0.01% |
| March 3, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 2750 | $0.00 | 1,472,194.0000 | 127,691,329 | 0.19% | 0.00% |
| March 2, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 1860 | $23.18 | 1,474,944.0000 | 127,691,329 | 0.13% | 0.00% |
| March 2, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 14292 | $22.67 | 1,476,804.0000 | 127,691,329 | 0.96% | 0.01% |
| Feb. 26, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | A | Class A Common Stock | 157895 | $0.00 | 1,491,096.0000 | 127,691,329 | 11.84% | 0.12% |
| Feb. 23, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 9632 | $18.58 | 1,333,201.0000 | 127,691,329 | 0.72% | 0.01% |
| Jan. 5, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | M | Stock Option (right to buy) | 17463 | $0.00 | 0.0000 | 127,691,329 | 100.00% | 0.01% |
| Jan. 5, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | M | Class A Common Stock | 50000 | $1.20 | 1,342,833.0000 | 127,691,329 | 3.87% | 0.04% |
| Jan. 5, 2026 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | M | Stock Option (right to buy) | 32537 | $0.00 | 173,600.0000 | 127,691,329 | 15.78% | 0.03% |
| Nov. 24, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 13261 | $19.00 | 1,292,833.0000 | 125,502,291 | 1.02% | 0.01% |
| Sept. 12, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 900 | $0.00 | 1,306,094.0000 | 120,451,550 | 0.07% | 0.00% |
| Aug. 22, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 9348 | $13.79 | 1,306,994.0000 | 120,451,550 | 0.71% | 0.01% |
| June 9, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 1000 | $0.00 | 1,316,342.0000 | 120,451,550 | 0.08% | 0.00% |
| May 29, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 3000 | $0.00 | 1,317,342.0000 | 120,451,550 | 0.23% | 0.00% |
| May 22, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 9343 | $8.30 | 1,320,342.0000 | 120,451,550 | 0.70% | 0.01% |
| March 17, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | A | Class A Common Stock | 171428 | $0.00 | 1,329,685.0000 | 120,451,550 | 14.80% | 0.14% |
| Feb. 28, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 7942 | $10.63 | 1,108,257.0000 | 120,451,550 | 0.71% | 0.01% |
| March 4, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | M | Class A Common Stock | 50000 | $1.20 | 1,158,257.0000 | 120,451,550 | 4.51% | 0.04% |
| March 4, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | M | Stock Option (right to buy) | 50000 | $0.00 | 17,463.0000 | 120,451,550 | 74.11% | 0.04% |
| Feb. 24, 2025 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 5092 | $11.07 | 1,116,199.0000 | 120,451,550 | 0.45% | 0.00% |
| Dec. 23, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | M | Class A Common Stock | 12000 | $1.20 | 1,121,291.0000 | 120,733,030 | 1.08% | 0.01% |
| Dec. 23, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | M | Stock Option (right to buy) | 12000 | $0.00 | 67,463.0000 | 120,733,030 | 15.10% | 0.01% |
| Nov. 21, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 1850 | $0.00 | 1,115,984.0000 | 120,733,030 | 0.17% | 0.00% |
| Nov. 22, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 6693 | $13.69 | 1,109,291.0000 | 120,733,030 | 0.60% | 0.01% |
| Nov. 14, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 1350 | $0.00 | 1,117,834.0000 | 120,733,030 | 0.12% | 0.00% |
| Aug. 22, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 6749 | $22.53 | 1,119,184.0000 | 117,165,036 | 0.60% | 0.01% |
| May 29, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 425 | $0.00 | 1,125,933.0000 | 117,165,036 | 0.04% | 0.00% |
| May 22, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 4877 | $24.30 | 1,126,358.0000 | 117,165,036 | 0.43% | 0.00% |
| March 21, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | A | Class A Common Stock | 88854 | $0.00 | 1,131,235.0000 | 117,165,036 | 8.52% | 0.08% |
| March 14, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | G | Class A Common Stock | 1086 | $0.00 | 1,042,381.0000 | 117,165,036 | 0.10% | 0.00% |
| March 4, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 4660 | $44.00 | 1,043,467.0000 | 117,165,036 | 0.44% | 0.00% |
| Feb. 22, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 2821 | $46.34 | 1,048,127.0000 | 117,165,036 | 0.27% | 0.00% |
| Feb. 15, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 3300 | $48.58 | 1,052,648.0000 | 117,165,036 | 0.31% | 0.00% |
| Feb. 15, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 1700 | $49.43 | 1,050,948.0000 | 117,165,036 | 0.16% | 0.00% |
| Feb. 9, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 1000 | $49.53 | 1,055,948.0000 | 117,165,036 | 0.09% | 0.00% |
| Jan. 16, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 1035 | $45.65 | 1,056,948.0000 | 117,165,036 | 0.10% | 0.00% |
| Jan. 16, 2024 | 10x Genomics, Inc. | $TXG | Saxonov Serge | Chief Executive Officer | S | Class A Common Stock | 2965 | $45.10 | 1,057,983.0000 | 117,165,036 | 0.28% | 0.00% |